MUM-1 (Multiple myeloma oncogene-1), catalog number PRM352 AA; Product Usage: For In Vitro Diagnostic Use. This antibody may be used as a tool for the identification and the sub classification of lymphoid malignancies : Multiple myeloma oncogene-1 (MUM-1) is a protein encoded by MUM-1 gene. MUM-1 protein is expressed in the nuclei and cytoplasm of plasma cells and a small percentage of germinal center (GC) B-cells located in the light zone. MUM-1 [BC5] labels MUM-1protein in centrocytes and their progeny, plasma cells, activated T-cells and a wide spectrum of hematolymphoid neoplasms derived from these cells. MUM-1 has been reported to play an important role in mediating B-cell activation and differentiation.
Publicado el 21 de enero de 2015 · Inicio del retiro: 12 de diciembre de 2014
Resumen
FDA registra el retiro Z-0965-2015 de dispositivos médicos de Clase II, publicado el 21 de enero de 2015 e iniciado el 12 de diciembre de 2014. Empresa responsable: Biocare Medical Llc; Estado: Finalizado; Cantidad reportada: 59; Lote: Lot 061013, Exp 2016/06; Lot 073013, Exp. 2016/07; Lot 071614, Exp. 2017/07. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Three lots of MUM-1 may not meet their labeled shelf life, as a drop in staining intensity over time has been observed.
Qué hacer
Voluntary: Firm initiated · Telephone
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Biocare Medical Llc
- Distribuidor
- Worldwide Distrinution - US Nationwide in the states of TX, WI, MO, WV, SC, MA, WA, TN, AZ, CA, IL, NY, LA and countries of Kuwait, India, Venezuela, New Zealand, Turkey, Uruguay.
- Lote
- Lot 061013, Exp 2016/06; Lot 073013, Exp. 2016/07; Lot 071614, Exp. 2017/07.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAHeartStart MRx Monitor/Defibrillator; Model. Numbers: M3535A, M3536A, M3536J, M3536M, M3536MC, M3536M2,21 de enero de 2015
- FDAVITROS 3600 Immunodiagnostic System, Catalog Number 6802783, IVD --- Ortho Clinical Diagnostics. For use in21 de enero de 2015
- FDAiPlan RT is a radiation treatment planning system that is intended for use in stereotactic, conformal,21 de enero de 2015
- FDAlnline Persuader- PedFuse Pedicle Screw System; Part Number: 11-8016421 de enero de 2015
- FDAGE Healthcare, Proteus XR/a with wall stand model number 600-0301.21 de enero de 2015
- FDATimberline Anchored Lateral Fixed Retractable Sleeve Model No. 8630-0205. Timberline Anchored Lateral Fixed21 de enero de 2015
Preguntas sobre este retiro
¿MUM-1 (Multiple myeloma oncogene-1), catalog number PRM352 AA; Product Usage: For In Vitro Diagnostic Use. This antibody may be used as a tool for the identification and the sub classification of lymphoid malignancies : Multiple myeloma oncogene-1 (MUM-1) is a protein encoded by MUM-1 gene. MUM-1 protein is expressed in the nuclei and cytoplasm of plasma cells and a small percentage of germinal center (GC) B-cells located in the light zone. MUM-1 [BC5] labels MUM-1protein in centrocytes and their progeny, plasma cells, activated T-cells and a wide spectrum of hematolymphoid neoplasms derived from these cells. MUM-1 has been reported to play an important role in mediating B-cell activation and differentiation. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0965-2015 el 21 de enero de 2015. Peligro reportado: Three lots of MUM-1 may not meet their labeled shelf life, as a drop in staining intensity over time has been observed.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Telephone